Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sander A. L. Palit
Observed names:
Palit, Sander,
Sander A.L. Palit,
Sander AL Palit,
Sander Palit
Institution:
MRC Holland (Netherlands)
Observed institutions:
Semmelweis University,
Radboud University Nijmegen,
Radboud University Medical Center,
The Netherlands Cancer Institute,
Radboud Institute for Molecular Life Sciences,
MRC Holland (Netherlands)
show all 6
ORCID:
0000-0003-2487-4311
Observed ORCID:
0000-0003-2487-4311
OpenAlex ID:
A5063815622
Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress
2015
·
Laurensia Yuniati
, Laurens T. van der Meer
, et al.
·
Oncotarget
·
44
PDF
Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L‐dose dependency in HDAC1‐deficient thymic lymphoma
2019
·
Hanneke Vlaming
, Chelsea M. McLean
, et al.
·
The EMBO Journal
·
41
PDF
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth
2019
·
Sander AL Palit
, Daniel Vis
, et al.
·
eLife
·
40
Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2016
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
·
Molecular Cancer Research
·
24
A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer
2021
·
Sander A. L. Palit
, Jeroen van Dorp
, et al.
·
Scientific Reports
·
18
PDF
Molecular Profiling Reveals Novel Gene Fusions and Genetic Markers for Refined Patient Stratification in Pediatric Acute Lymphoblastic Leukemia
2025
·
Borbála Péterffy
, Szilvia Krizsán
, et al.
·
Modern Pathology
·
11
PDF
Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications
2025
·
Daniel J. Vis
, Sander A. L. Palit
, et al.
·
Genome Medicine
·
9
Author response: TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth
2019
·
Sander AL Palit
, Daniel Vis
, et al.
·
eLife
·
1
Optical genome mapping enhanced by refined variant interpretation in pediatric acute lymphoblastic leukemia
2026
·
Anna Bekő
, Borbála Péterffy
, et al.
·
The Journal of Pathology
Comprehensive Characterisation of the Copy Number Landscape in Acute Lymphoblastic Leukemia Using Digitalmlpa
2023
·
Anne Benard-Slagter
, Sander Palit
, et al.
·
Blood
Supplemental doc from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
PDF
Table S1 from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
Table S3 from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
Table S6 from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
Table S4 from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
Table S5 from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
Table S2 from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
Data from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
Data from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
Table S6 from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
Table S2 from Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma
2023
·
Guus J.J.E. Heynen
, Ekaterina Nevedomskaya
, et al.
Abstract 972: MMR-deficiency is the most prominent genetic feature of prostate cancer metastases organotropism
2022
·
Daniel Vis
, Sander Palit
, et al.
·
Cancer Research
Decoding androgen receptor inhibitor resistance in prostate cancer
2022
·
Palit, Sander
·
Utrecht University Repository (Utrecht University)
PDF
The Leukemia-Associated Protein BTG1 Is Required for ATF4-Mediated Cellular Stress Responses
2014
·
Laurensia Yuniati
, Laurens T van der Meer
, et al.
·
Blood
Show more works
View as search
Works count:
24
Citation count:
188
H-index:
7
I10-index:
6
Year
Topic
Type